STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 27,409	$ 21,834
General and administrative	6,934	7,281
Total operating expenses	34,343	29,115
Loss from operations	(34,343)	(29,115)
Other income, net	2,912	1,397
Net loss	$ (31,431)	$ (27,718)
Per share information:
Net loss per share of common stock, basic	$ (0.42)	$ (0.58)
Net loss per share of common stock, diluted	$ (0.42)	$ (0.58)
Weighted average common shares outstanding, basic	75,735,954	47,737,190
Weighted average common shares outstanding, diluted	75,735,954	47,737,190
Comprehensive loss
Net loss	$ (31,431)	$ (27,718)
Unrealized (loss) gain on marketable securities, net of tax	(458)	1,294
Comprehensive loss	$ (31,889)	$ (26,424)